Study of TGM-312-SC01 in Healthy Participants and Adults With MASH
Recruiting
Phase 1
Phase 2
Interventional Study
Healthy Participants
MASH - Metabolic Dysfunction-Associated Steatohepatitis
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 – 70
- Sex
- Any
- Trial phase
- Phase 1/2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 99 (estimated)
- Sponsor
- Tangram Therapeutics Plc · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamic (PD) effects of single ascending doses of TGM-312-SC01 in healthy adults and multiple ascending doses in patients with metabolic dysfunction-associated steatohepatitis (MASH).
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adults aged 18 to 70 years who are able to provide written informed consent.
* Medically suitable for study participation based on protocol-defined assessments.
* For the disease cohort, participants with clinical features consistent with metabolic dysfunction-associated steat…
Contacts